Concepedia

Matthew Chow

MC

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Matthew Chow is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in platelet activation, high-throughput synthesis, and chemical engineering.

ORCID

Publications per year

2009–2024

4

Publications

4

Sepsis Alters the Megakaryocyte–Platelet Transcriptional Axis Resulting in Granzyme B–mediated Lymphotoxicity

Robert J. Freishtat, JoAnne E. Natale, Angela S. Benton et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 62 citations

, , +17

Manufacturing Process Development for Belzutifan, Part 5: A Streamlined Fluorination–Dynamic Kinetic Resolution Process

Tao Wang, Eric M. Phillips, Stephen M. Dalby et al. · Organic Process Research & Development · 2021 · 43 citations

, , +15

Evolution of a Green and Sustainable Manufacturing Process for Belzutifan: Part 3─Development of a Scalable Enzymatic Oxidation Process

Jungchul Kim, Victoria Zhang, Kotoe Abe et al. · Organic Process Research & Development · 2024 · 19 citations

, , +17

Evolution of a Green and Sustainable Manufacturing Process for Belzutifan: Part 2─Development of a Scalable Nickel-Catalyzed Sulfonylation

J. Caleb Hethcox, Jungchul Kim, Heather C. Johnson et al. · Organic Process Research & Development · 2024 · 13 citations

, , +17

1–4 of 4